CRSP
Price
$52.17
Change
+$0.50 (+0.97%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
4.19B
39 days until earnings call
SAVA
Price
$2.01
Change
-$0.00 (-0.00%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
89.37M
27 days until earnings call
Interact to see
Advertisement

CRSP vs SAVA

Header iconCRSP vs SAVA Comparison
Open Charts CRSP vs SAVABanner chart's image
CRISPR Therapeutics AG
Price$52.17
Change+$0.50 (+0.97%)
Volume$117.06K
Capitalization4.19B
Cassava Sciences
Price$2.01
Change-$0.00 (-0.00%)
Volume$13.53K
Capitalization89.37M
CRSP vs SAVA Comparison Chart in %
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. SAVA commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongBuy and SAVA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CRSP: $51.67 vs. SAVA: $2.01)
Brand notoriety: CRSP and SAVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 123% vs. SAVA: 114%
Market capitalization -- CRSP: $4.19B vs. SAVA: $89.37M
CRSP [@Biotechnology] is valued at $4.19B. SAVA’s [@Biotechnology] market capitalization is $89.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileSAVA’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • SAVA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRSP and SAVA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while SAVA’s TA Score has 5 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 4 bearish.
  • SAVA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than SAVA.

Price Growth

CRSP (@Biotechnology) experienced а +8.41% price change this week, while SAVA (@Biotechnology) price change was +8.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

SAVA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.19B) has a higher market cap than SAVA($89.4M). CRSP YTD gains are higher at: 31.275 vs. SAVA (-14.831). SAVA has higher annual earnings (EBITDA): -145.89M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. SAVA (117M). SAVA has less debt than CRSP: SAVA (0) vs CRSP (219M). CRSP has higher revenues than SAVA: CRSP (35M) vs SAVA (0).
CRSPSAVACRSP / SAVA
Capitalization4.19B89.4M4,687%
EBITDA-455.24M-145.89M312%
Gain YTD31.275-14.831-211%
P/E RatioN/AN/A-
Revenue35M0-
Total Cash1.86B117M1,585%
Total Debt219M0-
FUNDAMENTALS RATINGS
CRSP vs SAVA: Fundamental Ratings
CRSP
SAVA
OUTLOOK RATING
1..100
3074
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9497
PRICE GROWTH RATING
1..100
3964
P/E GROWTH RATING
1..100
81100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SAVA's Valuation (21) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRSP (66) in the Biotechnology industry. This means that SAVA’s stock grew somewhat faster than CRSP’s over the last 12 months.

SAVA's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CRSP (100) in the Biotechnology industry. This means that SAVA’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's SMR Rating (94) in the Biotechnology industry is in the same range as SAVA (97) in the Pharmaceuticals Other industry. This means that CRSP’s stock grew similarly to SAVA’s over the last 12 months.

CRSP's Price Growth Rating (39) in the Biotechnology industry is in the same range as SAVA (64) in the Pharmaceuticals Other industry. This means that CRSP’s stock grew similarly to SAVA’s over the last 12 months.

CRSP's P/E Growth Rating (81) in the Biotechnology industry is in the same range as SAVA (100) in the Pharmaceuticals Other industry. This means that CRSP’s stock grew similarly to SAVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPSAVA
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 22 days ago
84%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGBGX39.740.07
+0.18%
American Funds Global Balanced R6
NBHRX14.72N/A
N/A
Neuberger Berman Equity Income R3
DHPAX17.71N/A
N/A
Diamond Hill Mid Cap Inv
GAOZX21.64N/A
N/A
JPMorgan Global Allocation R6
GGLIX13.81-0.01
-0.07%
abrdn US Sustainable Leaders Instl

SAVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SAVA has been loosely correlated with CRSP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SAVA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAVA
1D Price
Change %
SAVA100%
+8.65%
CRSP - SAVA
35%
Loosely correlated
+6.51%
IBRX - SAVA
29%
Poorly correlated
+2.72%
LXRX - SAVA
26%
Poorly correlated
+3.03%
AMRN - SAVA
26%
Poorly correlated
-0.95%
VKTX - SAVA
26%
Poorly correlated
+3.94%
More